Risperidone: A Novel Antipsychotic Medication
Abstract
Risperidone appears to be a significant advance in the treatment of schizophrenia. Its effectiveness for other serious psychiatric conditions, such as schizoaffective disorder and manic-depressive illness, has not been systematically studied. Further research is also needed to examine whether risperidone will be beneficial and adequately tolerated in special patient populations, including adolescents, the elderly, and psychiatric patients with concomitant medical illnesses.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
